The functional alliance between ZEB1 and YAP promotes the transcription of a common ZEB1/YAP target gene set, which represents a predictor of poor survival, therapy resistance, and increased metastatic risk in breast and pancreatic cancers [21, 23, 25]. This evidence concerns the gene ZEB1 and familial pancreatic carcinoma.